Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Parkinson's Disease

  Free Subscription


1 BMC Neurol
2 Exp Brain Res
2 Exp Neurol
1 Int J Neurosci
1 J Neural Transm (Vienna)
2 J Neurol Neurosurg Psychiatry
4 Lancet
8 Lancet Neurol
2 Mov Disord
1 Neurobiol Dis
1 Neurochem Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. YANG X, Gan J, Ji Y
    Association between cerebrospinal fluid pressure and cognition in patients with Alzheimer's disease and Lewy body dementia.
    BMC Neurol. 2024;24:35.
    PubMed         Abstract available

    Exp Brain Res

  2. HERLIHY RA, Alicandri F, Berger H, Rehman H, et al
    Investigation of non-invasive focused ultrasound efficacy on depressive-like behavior in hemiparkinsonian rats.
    Exp Brain Res. 2024;242:321-336.
    PubMed         Abstract available

  3. JASTER JH, Ong J, Ottaviani G
    Visual motion hypersensitivity, from spaceflight to Parkinson's disease-as the chiasmatic cistern may be impacted by microgravity together with normal terrestrial gravity-opposition physiology in the brain.
    Exp Brain Res. 2024 Jan 22. doi: 10.1007/s00221-024-06780.

    Exp Neurol

  4. SEILER JL, Zhuang X, Nelson AB, Lerner TN, et al
    Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression.
    Exp Neurol. 2024;374:114693.
    PubMed         Abstract available

  5. DAADI EW, Daadi ES, Oh T, Li M, et al
    Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.
    Exp Neurol. 2024 Jan 23:114694. doi: 10.1016/j.expneurol.2024.114694.
    PubMed         Abstract available

    Int J Neurosci

  6. YILMAZ M, Atik-Altinok Y, Seyidoglu D, Acarer A, et al
    Evaluation of Sarcopenia and Phase Angle in Elderly Patients with Parkinson's Disease.
    Int J Neurosci. 2024 Jan 26:1-12. doi: 10.1080/00207454.2024.2310180.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  7. QIN Y, Meng DT, Jin ZH, Du WJ, et al
    Association between autonomic dysfunction with motor and non-motor symptoms in patients with Parkinson's disease.
    J Neural Transm (Vienna). 2024 Jan 22. doi: 10.1007/s00702-024-02745.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  8. SANDOVAL-INSAUSTI H, Flores-Torres MH, Bjornevik K, Cortese M, et al
    Flavonoid intake and risk of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 24:jnnp-2023-332672.
    PubMed         Abstract available

  9. FAGGIANELLI F, Witjas T, Azulay JP, Benatru I, et al
    ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 25:jnnp-2023-332551.
    PubMed         Abstract available


    What next in Parkinson's disease?
    Lancet. 2024;403:219.

  11. BEN-SHLOMO Y, Darweesh S, Llibre-Guerra J, Marras C, et al
    The epidemiology of Parkinson's disease.
    Lancet. 2024;403:283-292.
    PubMed         Abstract available

  12. MORRIS HR, Spillantini MG, Sue CM, Williams-Gray CH, et al
    The pathogenesis of Parkinson's disease.
    Lancet. 2024;403:293-304.
    PubMed         Abstract available

  13. FOLTYNIE T, Bruno V, Fox S, Kuhn AA, et al
    Medical, surgical, and physical treatments for Parkinson's disease.
    Lancet. 2024;403:305-324.
    PubMed         Abstract available

    Lancet Neurol

  14. HOGLINGER GU, Adler CH, Berg D, Klein C, et al
    A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria.
    Lancet Neurol. 2024;23:191-204.
    PubMed         Abstract available

  15. SIMUNI T, Chahine LM, Poston K, Brumm M, et al
    A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research.
    Lancet Neurol. 2024;23:178-190.
    PubMed         Abstract available

    Parkinson's eponym.
    Lancet Neurol. 2024;23:143.

  17. MOHAMED W, Eltantawi MA, Mecheri Y, Zewde YZ, et al
    The AfrAbia(+plus) Parkinson's Disease Genomic Consortium.
    Lancet Neurol. 2024;23:140-141.

  18. DARWEESH SKL, Sampaio C, Bloem BR
    Has the time come to redefine Parkinson's disease?
    Lancet Neurol. 2024;23:130-133.

  19. OBESO JA, Calabressi P
    Parkinson's disease is a recognisable and useful diagnostic entity.
    Lancet Neurol. 2024;23:133-134.

  20. ZIMRAN A, Revel-Vilk S, Becker-Cohen M, Istaiti M, et al
    Venglustat in GBA1-related Parkinson's disease.
    Lancet Neurol. 2024;23:137.

  21. SARDI SP
    Venglustat in GBA1-related Parkinson's disease - Authors' reply.
    Lancet Neurol. 2024;23:137-138.

    Mov Disord

  22. MARRAS C, Fereshtehnejad SM, Berg D, Bohnen NI, et al
    Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
    Mov Disord. 2024 Jan 20. doi: 10.1002/mds.29708.
    PubMed         Abstract available

  23. EIDEM LE, Birkeland E, Austdal M, Bardsen K, et al
    Fatigue in Parkinson's Disease: A Proteomic Study of Cerebrospinal Fluid.
    Mov Disord. 2024 Jan 20. doi: 10.1002/mds.29715.

    Neurobiol Dis

  24. IMARISIO A, Yahyavi I, Avenali M, Di Maio A, et al
    Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease.
    Neurobiol Dis. 2024;192:106413.
    PubMed         Abstract available

    Neurochem Res

  25. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Jan 26. doi: 10.1007/s11064-024-04099.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.